Skip to content

The efficacy of the endoscopic findings after neoadjuvant chemotherapy for gastric cancer.

The efficacy of the endoscopic findings after neoadjuvant chemotherapy for gastric cancer. - The efficacy of the endoscopic findings after neoadjuvant chemotherapy for gastric cancer.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000033088
Enrollment
50
Registered
2018-07-01
Start date
2018-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Interventions

None listed

Sponsors

Osaka Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: We included gastric cancer patients who underwent surgery after chemotherapy.

Exclusion criteria

Exclusion criteria: Linitis plastica.

Design outcomes

Primary

MeasureTime frame
The relationship between endoscopic efficacy assessments before neoadjuvant chemotherapy and JCGC histological criteria in the gastric cancer patient who underwent chemotherapy before surgery

Countries

Japan

Contacts

Public ContactKazuhiro Ota

Osaka Medical College Second Department of Internal Medicine

clash_kaz@yahoo.co.jp072-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026